The MNBN, MONO, and APO frequencies with the MTRR 66GG genotype were significantly increased compared to those with the MTRR 66AA genotype at 6 nmol/L B6 in both the breast cancer cases and controls. This evidence concerns the gene AOPEP and breast cancer.